Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Guibing Ren"'
Autor:
Wenqi Wu, Yanan Jiang, Donghui Xing, Yixin Zhai, Huimeng Sun, Xiang He, Kaiping Luo, Pengpeng Xu, Feng Pan, Guolei Dong, Guibing Ren, Zhigang Zhao
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Acute myeloid leukemia (AML) with mixed-lineage leukemia (MLL) gene rearrangements (MLL-r) is an aggressive subtype of blood cancer with dismal prognosis, underscoring the urgent need for novel therapeutic strategies. E1A-binding protein (EP
Externí odkaz:
https://doaj.org/article/e204dd6e3ae1463ab00ca9e5135925bf
Autor:
Shifeng Xu, Yuan Guo, Yanwu Zeng, Zhijian Song, Xiaodan Zhu, Ning Fan, Zhilei Zhang, Guibing Ren, Yunjin Zang, Wei Rao
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The goal of this study is to disclose the clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. Methods A total of 86 Chinese patients were enrolled in this study. A p
Externí odkaz:
https://doaj.org/article/1c2d8da7930b4a9c9abb6f3657ecfcd9
Autor:
Yuan Guo, Wei Rao, Yanwu Zeng, Shifeng Xu, Guibing Ren, Zhilei Zhang, Xiaodan Zhu, Zhijian Song, Ning Fan, Yunjin Zang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background The goal of this study is to disclose the clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. Methods A total of 86 Chinese patients were enrolled in this study. A panel of 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32878a7afa9890532b9785058a53337f
https://doi.org/10.1186/s12885-021-07792-x
https://doi.org/10.1186/s12885-021-07792-x
Autor:
Shifeng Xu, Guo, Yuan, Yanwu Zeng, Zhijian Song, Xiaodan Zhu, Fan, Ning, Zhilei Zhang, Guibing Ren, Zang, Yunjin, Rao, Wei
Additional file 1: Supplemental Table 1. The actionability of driver genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ca2ff7bba5e709239b92416e8785b9
Autor:
Shifeng Xu, Guo, Yuan, Yanwu Zeng, Zhijian Song, Xiaodan Zhu, Fan, Ning, Zhilei Zhang, Guibing Ren, Zang, Yunjin, Rao, Wei
Additional file 2: Supplemental Table 2. Fusion events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079fb2de8e86c564a3fd4fb03dec8bf5
Autor:
Shifeng Xu, Guo, Yuan, Yanwu Zeng, Zhijian Song, Xiaodan Zhu, Fan, Ning, Zhilei Zhang, Guibing Ren, Zang, Yunjin, Rao, Wei
Additional file 3: Supplemental Table 3. Comparison of mutational frequency for the top 10 mutated genes between the Chinese and Western cohorts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc11aa68770a675019b4a890bca2b47e
Autor:
Zhijian Song, Zang Yunjin, Shifeng Xu, Yuan Guo, Guibing Ren, Zhilei Zhang, Wei Rao, Yanwu Zeng, Fan Ning, Xiaodan Zhu
Background The goal of this study is to disclose the clinically significant genomic alterations in patients with intrahepatic cholangiocarcinoma of the Chinese and Western populations.Methods A total of 86 Chinese patients were enrolled in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83c404f226612bc94412a1a4a1bcca7
https://doi.org/10.21203/rs.3.rs-25576/v1
https://doi.org/10.21203/rs.3.rs-25576/v1
Autor:
Guibing Ren, Zhilei Zhang, Xiaodan Zhu, Ning Fan, Shifeng Xu, Yuan Guo, Wei Rao, Yunjin Zang, Xin Zhang
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
Introduction. Intrahepatic cholangiocarcinoma (ICC) exhibited increasing incidence and mortality around the world, with a 35% five-year survival rate. In this study, the genetic alteration of primary ICC and metastasis ICC was exhibited to discover n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f758e3a524036c2e34118638011781
https://doaj.org/article/a85fca7c47b04b76a99415f923e8ff17
https://doaj.org/article/a85fca7c47b04b76a99415f923e8ff17
Autor:
Jiangong Wang, Junping Shi, Guibing Ren, Ming Yao, Milind Javle, Weiyu Hu, Guilan Dong, Jianping Wang, Shifeng Xu, Yuanwen Zheng, Yafei Wang, Wei Rao
Publikováno v:
Journal of Clinical Oncology. 38:e16652-e16652
e16652 Background: Biliary tract cancers (BTCs) are malignancies with poor prognosis and limited treatment options. MET is recurrently altered in various cancers that confer susceptibility to targeted MET inhibitors. It has been reported that the MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61e62d15c9a9bd8e0d0539b02f793a49
https://doi.org/10.1200/jco.2020.38.15_suppl.e16652
https://doi.org/10.1200/jco.2020.38.15_suppl.e16652
Autor:
Guibing R; Department of Oncological Surgery, Affiliated Hospital, Logistics University of the Chinese People's Armed Police Force, Tianjin, 300162, PR China., Xiping Z; Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, PR China.; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Xiaowen D; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Dehong Z; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Hongjiang Y; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Xiaoru M; Department of Oncological Surgery, Affiliated Hospital, Logistics University of the Chinese People's Armed Police Force, Tianjin, 300162, PR China., Wenju M; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Xiangming H; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China., Shuai Z; Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, PR China.
Publikováno v:
African journal of traditional, complementary, and alternative medicines : AJTCAM [Afr J Tradit Complement Altern Med] 2017 Jan 13; Vol. 14 (2), pp. 103-124. Date of Electronic Publication: 2017 Jan 13 (Print Publication: 2017).